-+ 0.00%
-+ 0.00%
-+ 0.00%

LIGAND PHARMACEUTICALS, INC. : OPPENHEIMER RAISES TARGET PRICE TO $326 FROM $285

Reuters·08/03/2026 12:34:34

Please log in to view news